| Literature DB >> 25144712 |
Chao-Ju Chen1, Tsu-Lan Wu2, Po-Liang Lu1, Ying-Tsong Chen3, Chang-Phone Fung4, Yin-Ching Chuang5, Jung-Chung Lin6, L Kristopher Siu7.
Abstract
OBJECTIVE: Two plasmids carrying blaNDM-1 isolated from carbapenem-resistant Klebsiella pneumoniae (CR-KP) and carbapenem-resistant Escherichia coli (CR-EC) were sequenced. CR-KP and CR-EC were isolated from two Taiwanese patients without travel histories.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25144712 PMCID: PMC4140731 DOI: 10.1371/journal.pone.0104899
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Clinical features of patients carrying bla NDM-1.
| Patient | 1 (pLK-75, CR-KP) | 2 (pLK-78, CR-EC) |
| Age | 82 | 64 |
| Gender | Male | Female |
| Underlying disease | HTN, CAD, pulmonary TB, HBV, CKD, Parkinsonism | HTN, DM, stroke and ESRD with HD, schizophrenia |
| Admission period | 2012/09/05∼2012/10/10 | 2012/05/28∼2012/10/24 |
| Clinical diagnosis | Pneumonia | Pneumonia, septic shock, respiratory failure |
| NDM-1 bacteria isolation date | 2012/09/24 | 2012/09/29 |
| Source | Sputum | Sputum |
| Antibiotics | Ceftriaxone (9/4∼9/5), Piperacillin/Tazobactam (9/6∼9/20), Ciprofloxacin (9/24∼9/26), Ertapenem (9/27∼10/2), Isoniazid (6/28∼), Rifampin (6/28∼) | Piperacillin/Tazobactam (9/4∼9/19), Levofloxacin (9/14∼9/27), Linezolid (9/19∼10/1) Imipenem/Cilastatin (9/28∼10/2), Ceftriaxone (10/3∼10/11), Daptomycin (10/3∼10/17), Cefepime (10/12∼10/26) |
| Outcome | Improved | Improved |
Abbreviations: HTN, hypertension; CAD, coronary artery disease; TB, tuberculosis; HBV, hepatitis B; CKD, chronic kidney disease; ESRD, end-stage renal disease; HD, haemodialysis.
Antimicrobial susceptibility testing among bla NDM-1-carrying isolates and their transconjugants.
| Antibiotics | Patient 1 | Patient 2 | ||
|
| Transconjugant |
| Transconjugant | |
| Ampicillin | ≥32 µg/ml | ≥32 µg/ml | ≥32 µg/ml | ≥32 µg/ml |
| Cefazolin | ≥32 µg/ml | ≥32 µg/ml | ≥32 µg/ml | ≥32 µg/ml |
| Cefotaxime | ≥64 µg/ml | ≥64 µg/ml | ≥64 µg/ml | ≥64 µg/ml |
| Ceftazidime | ≥32 µg/ml | ≥32 µg/ml | ≥32 µg/ml | ≥32 µg/ml |
| Cefepime | ≥32 µg/ml | ≥32 µg/ml | ≥32 µg/ml | ≥32 µg/ml |
| Aztreonam | ≥32 µg/ml | ≥32 µg/ml | ≥32 µg/ml | ≥32 µg/ml |
| Cefoxitin | ≥32 µg/ml | ≥32 µg/ml | ≥32 µg/ml | ≥32 µg/ml |
| Ertapenem | ≥8 µg/ml | ≥8 µg/ml | ≥8 µg/ml | ≥8 µg/ml |
| Imipenem | ≥8 µg/ml | ≥8 µg/ml | ≥8 µg/ml | ≥8 µg/ml |
| Meropenem | ≥8 µg/ml | ≥8 µg/ml | ≥8 µg/ml | 4 µg/ml |
| Doripenem | ≥8 µg/ml | ≥8 µg/ml | ≥8 µg/ml | ≥8 µg/ml |
| Ciprofloxacin | ≥4 µg/ml | ≤0.06 µg/ml | ≥4 µg/ml | ≤0.06 µg/ml |
| Gentamicin | ≥16 µg/ml | ≥16 µg/ml | ≤1 µg/ml | ≤1 µg/ml |
| Amikacin | ≤4 µg/ml | ≤4 µg/ml | ≤4 µg/ml | ≤4 µg/ml |
| Colistin | ≤0.5 µg/ml | ≤0.5 µg/ml | 1 µg/ml | ≤0.5 µg/ml |
| Tigecycline | 0.5 µg/ml | ≤0.25 µg/ml | 1 µg/ml | ≤0.25 µg/ml |
| SXT | ≥4 µg/ml | 2 µg/ml | ≥4 µg/ml | 2 µg/ml |
SXT: Trimethoprim/sulfamethoxazole.
Trimethoprim/sulfamethoxazole MICs are presented according to the concentration of trimethoprim.
Figure 1Schematic maps of (a) pLK75 and (b) pLK78.
The black blocks on the outer circle are the coding DNA sequences of the positive strand, and the black blocks on the inner circle are the coding DNA sequences of the negative strand. The remarkable features are indicated. Consensus regions similar to other plasmids/replicons are marked with thick black lines inside the circles, with non-consensus sections between the conserved regions shown by thin lines. The 26-kb inversion regions are marked in the inner circles, and the flanking sequences are shown. The sequences at both ends of the inversion region are shown in bold. The positions of the 244-bp Tn3-like repeats (c) are marked by black arrowheads on the circles. The 244-bp repeat sequence is shown in (c). The putative inverted repeats flanking this sequence are shown in bold with an underline.
Figure 2Integration of the ISCR1 element and its nearby sequences, including the blaNDM-1 gene region, into a class 1 integron.
The circular transposition intermediate generated by ISCR1 is shown above. Integration at the sul1 locus of a class 1 integron resulted in the genetic environment identified as flanking the bla NDM-1 ‘common neighbourhood’ region in pLK75 and pLK78 (pLK78 is shown here). The remarkable features are indicated: IRs, inverted repeats; IntI, integrase gene of class 1 integron; ISCR1 (orf513), integrase gene of ISCR1; oriIS, origin of replication of the ISCR element.